Dramatic ibrutinib efficacy in Schnitzler syndrome with indolent lymphoma

Key Findings

• ●Dramatic ibrutinib efficacy in Schnitzler syndrome with indolent lymphoma

Referenced in (1 disease)

1. passsource metadataJun 1, 2026, 02:25 PMby pubmed-api

   DOI corrected to the PubMed/Crossref-registered value; the prior stored DOI was fabricated (resolved to an unrelated or non-existent article). A duplicate entry carrying a malformed PMID was removed from the manifest.

   tools: pubmed.esummary, crossref.works